Absence of PRKAR1A loss of heterozygosity in laser-captured microdissected pigmented nodular adrenocortical tissue from a patient with Carney complex caused by the novel nonsense mutation p.Y21X

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 52, Issue 8, 2008, Pages 1257-1263

  Almeida, Madson Q ^a   Brito, Luciana Pinto ^a   Domenice, Sorahia ^a   Costa, Marcia Helena Soares ^a   Pinto, Emilia Modolo ^a   Osório, Cynthia A Toledo ^b   Latronico, Ana Claudia ^a   Mendonca, Berenice B ^a   Fragoso, Maria Candida B V ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Pain Center   (Brazil)

Author keywords

Laser captured microdissection; LOH; PPNAD; PRKAR1A

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE REGULATORY SUBUNIT IALPHA; PRKAR1A PROTEIN, HUMAN;

ADOLESCENT; ADRENAL CORTEX; ARTICLE; BLOOD; CASE REPORT; CYTOLOGY; FEMALE; GENETICS; HETEROZYGOSITY LOSS; HUMAN; LASER; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA; PATHOLOGY; PEDIGREE; STOP CODON;

ADOLESCENT; ADRENAL CORTEX; CODON, NONSENSE; CYCLIC AMP-DEPENDENT PROTEIN KINASE RIALPHA SUBUNIT; FEMALE; HUMANS; LASERS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA; PEDIGREE;

EID: 58849160830     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302008000800009     Document Type: Article

References (21)

1. Stratakis CA, Kirschner LS, Carney JA. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab. 2001;86:4041-6.
2. Horvath A, Stratakis C. Primary pigmented nodular adrenocortical disease and Cushing's syndrome. Arq Bras Endocrinol Metabol. 2007;51:1238-44.
3. Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, et al. Mutations of the gene encoding the protein kinase A type l-alpha regulatory subunit in patients with the Carney complex. Nat Genet. 2000;26:89-92.
4. Casey M, Vaughan CJ, He J, Hatcher CJ, Winter JM, Weremowicz S, et al. Mutations in the protein kinase AR1 alpha regulatory subunit cause familial cardiac myxomas and Carney complex. J Clin Invest. 2000;106:R31-8.
5. Kirschner LS, Sandrini F, Monbo J, Lin JP, Carney JA, Stratakis CA. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex. Hum Mol Genet. 2000;9:3037-46.
6. Sandrini F, Stratakis C. Clinical and molecular genetics of primary pigmented nodular adrenocortical disease. Arq Bras Endocrinol Metabol. 2004;48:637-41.
7. Stratakis CA, Carney JA, Lin JP, Papanicolaou DA, Karl M, Kastner DL, et al. Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest. 1996;97:699-705.
8. Horvath A, Boikos S, Giatzakis C, Robinson-White A, Groussin L, Griffin KJ, et al. A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat Genet. 2006;38:794-800.
9. Tsilou ET, Chan CC, Sandrini F, Rubin Bl, Shen de F, Carney JA, et al. Eyelid myxoma in Carney complex without PRKAR1A allelic loss. Am J Med Genet A. 2004;130:395-7.
10. Bossis I, Voutetakis A, Matyakhina L, Pack S, Abu-Asab M, Bourdeau I, et al. A pleiomorphic GH pituitary adenoma from a Carney complex patient displays universal allelic loss at the protein kinase A regulatory subunit 1A (PRKARIA) locus. J Med Genet. 2004;41:596-600.
11. Groussin L, Jullian E, Perlemoine K, Louvel A, Leheup B, Luton JP, et al. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease. J Clin Endocrinol Metab. 2002;87:4324-9.
12. Groussin L, Kirschner LS, Vincent-Dejean C, Perlemoine K, Jullian E, Delemer B, et al. Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1 A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PP-NAD. Am J Hum Genet. 2002;71:1433-42.
13. Parhar IS, Ogawa S, Sakuma Y. Laser-captured single digoxigenin-labeled neurons of gonadotropin-releasing hormone types reveal a novel G protein-coupled receptor (Gpr54) during maturation in cichlid fish. Endocrinology. 2004;145:3613-8.
14. Francis DP, Willson K, Davies LC, Coats AJ, Piepoli M. Quantitative general theory for periodic breathing in chronic heart failure and its clinical implications. Circulation. 2000;102:2214-21.
15. Mavrakis M, Lippincott-Schwartz J, Stratakis CA, Bossis I. Depletion of type IA regulatory subunit (Rlalpha) of protein kinase A (PKA) in mammalian cells and tissues activates mTOR and causes autophagic deficiency. Hum Mol Genet. 2006;15: 2962-71.
16. Shattuck TM, Costa J, Bernstein M, Jensen RT, Chung DC, Arnold A. Mutational analysis of Smad3, a candidate tumor suppressor implicated in TGF-beta and menin pathways, in parathyroid adenomas and enteropancreatic endocrine tumors. J Clin Endocrinol Metab. 2002;87:3911-4.
17. Pinto EM, Billerbeck AE, Fragoso MC, Mendonca BB, Latronico AC. Deletion mapping of chromosome 17 in benign and malignant adrenocortical tumors associated with the Arg337His mutation of the p53 tumor suppressor protein. J Clin Endocrinol Metab. 2005;90:2976-81.
18. Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, et al. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab. 2000;85:1440-8.
19. Veugelers M, Wilkes D, Burton K, McDermott DA, Song Y, Goldstein MM, et al. Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkarla haploinsufficient mice. Proc Natl Acad Sci USA. 2004;101: 14222-7.
20. Danoff A, Jormark S, Lorber D, Fleischer N. Adrenocortical micronodular dysplasia, cardiac myxomas, lentigines, and spindle cell tumors. Report of a kindred. Arch Intern Med. 1987;147:443-8.
21. Kirschner LS, Kusewitt DF, Matyakhina L, Towns WH, 2nd, Carney JA, Westphal H, et al. A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues. Cancer Res. 2005;65:4506-14.